NICORETTE COOLDROPS nicotine 2mg lozenge bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

nicotine polacrilex, Quantity: 10 mg (Equivalent: nicotine, Qty 2 mg)

Available from:

Johnson & Johnson Pacific Pty Ltd

INN (International Name):

Nicotine polacrilex

Pharmaceutical form:

Lozenge

Composition:

Excipient Ingredients: sodium carbonate; acesulfame potassium; xanthan gum; sucralose; magnesium stearate; purified water; hypromellose; titanium dioxide; mannitol; polysorbate 80; Flavour; stearic acid; mica

Administration route:

Buccal

Units in package:

20 x 4, 20, 20 x 8, 20 x 6

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. In smokers unable or not ready to stop smoking abruptly, the lozenge may also be used as part of a smoking reduction strategy as a step towards stopping completely.

Product summary:

Visual Identification: An oval, white to off-white film-coated lozenge with a size of about 14 x 9 x 7 mm, imprinted with ?n on one side and ?2? on the other side.; Container Type: Bottle; Container Material: PP; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Registered

Authorization date:

2013-01-24